"10.1371_journal.pone.0128816","plos one","2015-06-11T00:00:00Z","Ada H V Repetto-Llamazares; Roy H Larsen; Sebastian Patzke; Karianne G Fleten; David Didierlaurent; Alexandre Pichard; Jean Pierre Pouget; Jostein Dahle","Nordic Nanovector ASA, Kjelsåsveien 168, 0884, Oslo, Norway; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, 0310, Oslo, Norway; Sciencons AS, Kjelsåsveien 168, 0884, Oslo, Norway; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, 0310, Oslo, Norway; UMR 1037 INSERM/UPS, Centre de Recherche en Cancérologie de Toulouse, Toulouse, F-31062, France; Institut de Recherche en Cancérologie de Montpellier, Institut National de la Santé et de la Recherche Médicale, U896, Université Montpellier, Montpellier, France","Conceived and designed the experiments: AHVRL RHL SP DD AP JPP JD. Performed the experiments: AHVRL SP KGF DD AP. Analyzed the data: AHVRL SP KGF RHL DD AP JPP JD. Contributed reagents/materials/analysis tools: AHVRL SP KGF RHL DD AP JPP JD. Wrote the paper: AHVRL RHL SP DD AP JPP JD.","This study was funded in part by Nordic Nanovector ASA (http://www.nordicnanovector.com/). The authors Jostein Dahle and Ada H. V. Repetto-Llamazares are employed by Nordic Nanovector ASA, and Roy H. Larsen is a member of the Board of Nordic Nanovector ASA and Sciencons AS and the three of them are shareholders of Nordic Nanovector ASA. 177Lu-HH1 is the main product from Nordic Nanovector ASA. There are no patents, further products in development or further marketed products to declare. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials","2015","06","Ada H V Repetto-Llamazares","AHVRL",8,TRUE,7,5,8,7,TRUE,TRUE,FALSE,0,NA,FALSE
